Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Phantom Metatarsal Shortening System

K-Number: K223184 · 2022-12-16

Decision Date2022-12-16
Product CodeHWC
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Phantom Metatarsal Shortening System is a medical device manufactured by Paragon 28, Inc.. It received FDA 510(k) clearance on 2022-12-16 under approval number K223184. The device is classified under product code HWC. It was reviewed by the OR advisory panel. Product code HWC falls under the category of Cardiovascular, which includes vascular grafts and cardiovascular implants. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Phantom Metatarsal Shortening System?

Phantom Metatarsal Shortening System is a medical device that received FDA 510(k) clearance on 2022-12-16. It is manufactured by Paragon 28, Inc.. The 510(k) number is K223184.

When was Phantom Metatarsal Shortening System approved by the FDA?

Phantom Metatarsal Shortening System received FDA 510(k) clearance on 2022-12-16, under approval number K223184.

What company makes Phantom Metatarsal Shortening System?

Phantom Metatarsal Shortening System is manufactured by Paragon 28, Inc..

What is the FDA product code for Phantom Metatarsal Shortening System?

The FDA product code for Phantom Metatarsal Shortening System is HWC. This falls under the Cardiovascular category.

Related Clinical Trials

Other Devices by Paragon 28, Inc.

View all 50 devices →

Related Devices (Code: HWC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.